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Abstract
Genetic and environmental agents that disrupt organogenesis are numerous and well described.
Less well established, however, is the role of delay in the developmental processes that yield
functionally immature tissues at birth. Evidence is mounting that organs do not continue to develop
postnatally in the context of these organogenesis insults, condemning the patient to utilize under-
developed tissues for adult processes. These poorly differentiated organs may appear histologically
normal at birth but with age may deteriorate revealing progressive or adult-onset pathology. The
genetic and molecular underpinning of the proposed paradigm reveals the need for a
comprehensive systems biology approach to evaluate the role of maternal-fetal environment on
organogenesis.
You may delay, but time will not
Benjamin Franklin
USA Founding Father
Background
The fragility of the developmental process is well known
with estimates as high as 70% of conceptions lost in early
pregnancy [1]. Genetic defects are known to produce
numerous changes in both metabolic and morphologic
characteristics of the fetus [2]. The choreography of genes
necessary for successful fetal development is amply dem-
onstrated by embryonic lethal [3] and other phenotypes
[4-8] in knockout mouse models. Thus, genetic defects
introduced in the developmental cascade contribute to
structural malformations. But organogenesis requires the
genetic choreography to occur not just in sequence but
also during a sensitive time period. What happens when
the genes regulating the developmental time clock [9,10]
are mutated or delayed by epigenetic factors? Can the
organ continue to develop outside the fetal environment
and if not, what are the consequences of retaining fetal
characteristics in an adult?
The best model for addressing these questions related to
organogenesis and timing is the premature infant. Mod-
ern neonatology has extended viability to 23 weeks in the
40 week human gestation, but what are the consequences
of completing less than 60% of gestation on the human
fetus? The obvious immediate consequences seen in any
neonatal unit include poor lung function, intestinal defi-
ciencies, immune system deficiencies, and poor renal
function. These immediate problems combined with ther-
apies used to combat them can lead to significant morbid-
ity and mortality in the premature infant.
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Infants surviving the immediate organ deficiencies and
therapies of premature birth, however, do not grow into
healthy adult. Rather, numerous epidemiological and
clinical observations have shown that prematurity is asso-
ciated with many adult onset diseases (Table 1). The epi-
demiologic basis for late or adult-onset diseases,
following either premature birth or low birth weight,
includes poor pre-natal maternal nutrition and smoking
during pregnancy both of which are reviewed previously
[11,12]. But these epidemiologic correlations do no pro-
vide a theoretical, molecular basis for explaining late
onset of diseases related to delays in organogenesis.
Conceptualizing the effect of small developmental distur-
bances on solid organs such as the lung, liver, intestines
and kidneys can be difficult because morphological differ-
ences may be minor. If one considers an organ with func-
tional characteristics that are morphologic, however, then
the concept of developmental disruption becomes obvi-
ous. A good example would be the hand. Numerous
examples of impaired development through either genetic
defects or blood flow interruption result in obvious
deformities including webbing, polydactyl and complete
and partial absences of digits. Visualization of changes in
solid organ development is less obvious but the effects on
function have the same impact as a hand without a
thumb.
As an example, lung growth and development (Fig. 1A),
like the hand, is precisely timed throughout gestation
[13]. In humans functional respiratory structures are com-
plete by birth although alveolarization continues until an
adult number of alveoli are reached at 2–3 years of age;
however, in the mouse and rat functional alveolarization
is completed after birth by day of life (DOL) 5. The embry-
onic human lung can be identified at 28 days with trachea
and bronchi expanding from the lung bud. During the
pseudoglandular stage further branching occurs and the
airways are lined with multipotent stem cells. Branches of
terminal bronchioles are formed and respiratory bronchi-
oles begin as out pockets. These pockets of epithelial cells
expand during the saccular and alveolar stages to form ter-
minal alveoli which are necessary for gas exchange. Nor-
mal lung organogenesis is a carefully programmed process
that can be disrupted and result in abnormal lung struc-
ture and function.
Three types of disruptions can occur in lung organogene-
sis (Fig. 1B–D). The most obvious are genetic mutations
that completely block lung growth (Fig. 1B) resulting in a
non-functional lung and fetal or neonatal demise [14-16].
The less obvious yet equally important disruptions to nor-
mal lung function are those that impair or impede specific
events in organogenesis. A genetic mutation or environ-
mental insult to the fetus through the mother can result in
either a premature (Fig. 1C) or prolonged (Fig. 1D) tran-
sition to a later stage of development. In the former case,
structures, which are normally propagated, are lost along
with their function. In the latter case, slower growth
results in late development of important structures and
functions prior to normal birth. In both cases, the histo-
logic structure of the lung may grossly appear normal;
however, the actual functional equivalency of the cells
may be significantly altered.
Two questions arise from these models. First, can discon-
tinuity between stages in a developmental cascade alter
the cell type or their function? During each stage of orga-
nogenesis, stem cells are progressing through stages of
transit amplifying (TA) cells in which the functional char-
acteristics of each generation is maturing to that of a ter-
minally differentiated cell type (Fig. 2). During
organogenesis the environment progresses through differ-
ent temporal states (TS) in which the TA cells produce
products necessary for differentiation that are not neces-
sary needed for final functionality. As an example, in TS-A
(Fig. 2) may produce products that are required for devel-
opment of specialized structures. Proteins produced in TS-
B, however, may induce rapid cell growth and increased
tissue complexity. If this process is abbreviated as pro-
posed in Fig. 1C, then the terminal differentiation state
can not be reached and downstream functional character-
istics of the cell will be missing.
Secondly, when there is a delay in progression (Fig. 1D),
does normal organogenesis continue postnatally? Because
the fetal environment plays a significant role in differenti-
ation, preterm birth arrests organ development with
retention of fetal characteristics. Thus, all or part of the
organ would remain in a fetal temporal state (e.g. TS-B;
Fig. 2), significantly different from that of the terminally
differentiated tissue (TS-C, Fig. 2).
Delay and disruption of organogenesis could result in two
different phenotypes because the immature tissue would
be missing different functional gene sets. Distinguishing
these two would be dependent upon a developmental
gene expression knowledge base. However, it is possible
Table 1: Late-onset clinical presentations associated with 
premature birth.
Clinical Presentation References
Diabetes [27, 28, 62, 63]
Inflammatory Bowel Diseases [64]
Obesity [12, 63]
Cardiovascular Disease [28]
Asthma [65]
Sleep Disordered breathing [66]
Sudden Infant Death Syndrome (SIDS) [13, 67]Theoretical Biology and Medical Modelling 2008, 5:1 http://www.tbiomed.com/content/5/1/1
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to get similar morphologic phenotypes but different phys-
iology. As illustrated in Figure 3, if one takes a case in
which a protein is required for triggering the normal final
stage of complex organ architecture (Fig. 3A), disrupting
the stage that precedes this protein could result in its pre-
mature activation without sufficient support structure
(Fig. 3B), resulting in a hypoplastic structure. Likewise,
prolonging the preceding stage by delaying activation of
these proteins could lead to some gain in complexity in
the supporting structure. However, similar decreased
structural complexity of this final stage would result (Fig.
Architecture and developmental programming Figure 3
Architecture and developmental programming. Normal 
architecture depends on building layers that are based on both 
quantity and timing of components with an overall structural size 
limitation (Panel A). Premature activation of subsequent stages 
disrupts primary base structure requiring downstream compo-
nents to fill a space larger than normally required resulting in less 
complexity (Panel B). Likewise, prolonging production of the 
upstream components increases their complexity at the expense 
of downstream structures (Panel C), resulting in a hypoplastic 
structure similar to that seen in disrupted growth of upstream 
components.
Lung development and the effects of developmental disruption Figure 1
Lung development and the effects of developmental disruption. A-Normal lung differentiation; B-Disrupted growth; C-Prema-
ture transition resulting in abbreviated pseudoglandular stage; D-Delayed transition leading to incomplete canalicular and saccular/alveolar 
stages.
Stem cell differentiation during organogenesis Figure 2
Stem cell differentiation during organogenesis. Progression 
through varying transit amplifying (TA) cell stages of functional 
maturity (bottom gray scale) called temporal states (TS) A-C. Var-
ious geometric shapes (stars, ovals, triangles, etc) represent either 
intracellular, extracellular, or membrane associate markers of dif-
ferentiation.Theoretical Biology and Medical Modelling 2008, 5:1 http://www.tbiomed.com/content/5/1/1
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3C) due to a decrease in the time interval between activa-
tion of terminal differentiation and birth. Morphologi-
cally both tissues would appear hypoplasia of the
terminal structure; because the balance among structural
components is altered the physiology could be quite dif-
ferent. Thus, distinctions between delayed and disrupted
organogenesis will be dependent upon biochemical mak-
ers of differentiation, structural characteristics of the tis-
sue, and perhaps most importantly the physiologic
functions of the modified organ.
There are numerous examples of failed differentiation due
to specific gene defects leading to deficient cell types. In
the lung, mutations in lamellar body formation lead to
structural changes leading to chronic inflammatory dis-
eases [17-19]. Mutation of Arnt, a gene required for
hepatic vascularization, results in a persistent embryonic
liver phenotype that demonstrate decreased survival and
changes in fat and carbohydrate metabolism after birth
[20]. Bapx1 is required for separation of the pancreas and
spleen into distinct organs [21]. In each of these single
gene defects, slow or inhibited organogenesis results in a
suboptimal functioning organ and a subsequent pathol-
ogy.
The physical environment of the fetus can also impact the
dynamics of organogenesis. One of the more common
prototypes is congenital diaphragmatic hernias which
result in hypoplastic lung disease. Surgical blocking of the
trachea [22] or in utero cystic fibrosis transmembrane con-
ductance regulator (CFTR) gene therapy [23] to promote
stretch induced lung differentiation can reverse the effect,
but postnatally this condition has a poor prognosis with
high morbidity and mortality. Likewise, amniotic fluid
blockage to the intestines alters villus formation and func-
tion [24].
Probably the least understood and most subtle effectors of
developmental delay are fetal environmental insults.
Maternal smoking, alcohol consumption, diabetes, and
diehylstilbesterol use have all been linked to significant
long term consequences on the fetus [11,19,25-28].
Discussion
What are diseases of organogenesis that result from devel-
opmental delay and not disruption called? In premature
infants terms like fetal and immature are used to describe
their gestational correct, underdeveloped organs. We pro-
pose that the temporal state of many tissues can become
fixed at birth, resulting in organs that are functionally
immature. Thus, we use the term Peter Pan Paradigm for
diseases that occur due to developmental delay or disrup-
tion resulting in a seemingly histological, normal organ
with functional immaturity. Developmental delay pro-
duces tissues that at birth are in a gestational abnormal
temporal state, either fetal (e.g. TS-B; Fig. 2) or hybrid (e.g.
TS-B/C). Thus, like the fictional namesake, these affected
organs never fully mature and remain at a nexus between
the fetal and mature temporal states.
Changes in the organs trapped in either a complete or par-
tial fetal temporal state can be varied. As illustrated in Fig.
2 receptors and secreted products may be different. In
addition, functions such as regulated secretion could be
affected. This functional immaturity results in progressive
incapacitation of the organ with associated late-onset dis-
ease manifestations. Possible syndromes included in this
category would be any progressive or late-onset disease
that exhibited multi-factorial genetics. Obviously, these
diseases would present with very heterogeneous pheno-
types because the more severe the delay, the earlier the
average temporal state of the tissue.
The prototypical disease in the Peter Pan paradigm is
Cystic Fibrosis (CF). The natural history of this disease
includes progressive multi-system failure. There is a lack
of phenotype genotype correlation suggesting the role of
multiple genes or environment [29,30]. CF is a recessive
disorder yet the human phenotype can occur in the
absence of homozygous mutations in the CFTR gene [31]
and the heterozygous knockout mice have a unique lung
phenotype [32]. Expression during embryonic lung
growth is associated with genes required for normal devel-
opment [3,10,33]. CFTR expression occurs at high levels
in the developing lung [34] and other tissues [35]. Fur-
thermore, transient in utero replacement to increase or
decrease expression of CFTR in animal models alters the
lung and intestinal CF phenotype [23,36-43]. Thus, there
are multiple independent lines of evidence suggesting a
role of CFTR in normal organogenesis of the lung, intes-
tines, and other organs.
Born with more or less normal histology of the lung, pan-
creas, and liver, but with a more serious intestinal pheno-
type, CF patients exhibit progressive lung disease largely
blamed on decreased mucous hydration [44,45]. How-
ever, the hypothesis that the altered water balance and
resultant inflammatory lung disease is due solely to lack
of CFTR in the post-natal lung is contradicted by both the
CF phenotype in the absence of CFTR mutations [31] and
the finding of CF-like lung disease following transient in
utero knockout of CFTR [38]. Thus, the lung disease is con-
sistent with the presence of under differentiated cells that
maintain a functionally immature phenotype in a struc-
ture; that initially exhibits normal histology; and that con-
tribute to the altered mucous phenotype. Environmental
challenges to the lungs as they age result in increased
infections and the bronchiectasis. A similar process under-
pins CF-related diabetes [46,47] and liver function
decreases with time resulting in disease [48].Theoretical Biology and Medical Modelling 2008, 5:1 http://www.tbiomed.com/content/5/1/1
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As previously described regarding progression of develop-
ment from one stage to another (Fig. 1), the recent finding
that CFTR influences stretch-induced differentiation [37]
further delineates CF as a Peter Pan disease. Stretch
induced differentiation is essential for normal lung devel-
opment [49-52]. Amniotic fluid flow is also essential for
normal gut differentiation [24]. Thus, the major organs
involved in the CF phenotype are all dependent upon
amniotic fluid flow and mechanochemical regulated dif-
ferentiation [51,53]. In the total absence of CFTR this flow
would be dependent upon other, less effective, mecha-
nisms to drive development such as rho kinase [54] and
fetal breathing [55]. In addition, environmental exposure
of the mother to nicotine or other agents could affect the
final phenotype by affecting muscle contractions neces-
sary for stretch induction [25,56,57]. Thus, the lack of
phenotype-genotype correlation and a common mechan-
ochemical origin would account for the variable effects
seen in multiple organ systems.
The intestine may be one of the more susceptible organs
for Peter Pan diseases. As discussed earlier inflammatory
bowel diseases are linked epidemiologically with prema-
turity (Table 1). Thus, delay in intestinal development
could alter cell maturation and the metabolic balance of
the intestines. One of the most common Peter Pan dis-
eases may prove to be obesity and diabetes. The ability to
maintain metabolic balance depends on developmental
and transcriptional control systems of the intestinal epi-
thelium [58,59]. Thus, interruption or delay leading to
under differentiation of intestinal epithelium would have
a significant impact on metabolic activity. In what may be
considered an early prelude to Peter Pan Paradigm, a rela-
tionship between metabolic balance and fetal develop-
ment was originally proposed in the "Thrifty Phenotype
Hypothesis"[60].
Lung diseases such as asthma, allergies, and sudden infant
death syndrome (SIDS) may be related to delay in devel-
opment. All of these conditions are associated with pre-
maturity (Table 1) and from Fig. 1, one can readily
visualize how slowing progress in differentiation of suc-
ceeding structures would have a cascading effect on lung
function. The central role of stretch-induced differentia-
tion to lung development [37,51,53,54] strongly suggests
that deficiencies in amniotic fluid volume, depression of
fetal breathing [55], or inhibition of smooth muscle con-
tractions [49,52] with agents such as nicotine [57] could
depress and delay differentiation of the bronchioles lead-
ing to under differentiated cell types and airways. In fact
this is the case as previous studies showed persistence of
fetal gene expression and functional immature phenotype
in allergic asthma [61].
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